PHS
PFM Health Sciences Portfolio holdings
AUM
$1.15B
This Quarter Return
+34.3%
1 Year Return
+21.39%
3 Year Return
+130.75%
5 Year Return
+265.32%
10 Year Return
+1,236.5%
AUM
$1.64B
AUM Growth
+$1.64B
(+35%)
Cap. Flow
+$192M
Cap. Flow
% of AUM
11.73%
Top 10 Holdings %
Top 10 Hldgs %
38.22%
Holding
89
New
20
Increased
15
Reduced
21
Closed
18
Top Buys
| 1 |
IMMU
Immunomedics Inc
IMMU
|
$75M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$63.5M |
| 3 |
Labcorp
LH
|
$51.5M |
| 4 |
Hologic
HOLX
|
$35M |
| 5 |
AstraZeneca
AZN
|
$33.6M |
Top Sells
| 1 |
Pfizer
PFE
|
$38.5M |
| 2 |
Becton Dickinson
BDX
|
$34.7M |
| 3 |
Cigna
CI
|
$34.5M |
| 4 |
Elevance Health
ELV
|
$32.6M |
| 5 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
$30.7M |
Sector Composition
| 1 | Healthcare | 78.58% |
| 2 | Technology | 5.03% |
| 3 | Consumer Discretionary | 1.56% |
| 4 | Industrials | 0.73% |
| 5 | Financials | 0.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMMU
1
DELISTED
Immunomedics Inc
IMMU
| $113M | 5.84% | 3,178,974 +2,114,933 | +199% | +$75M |
|
|
ALXN
2
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $76.2M | 3.95% | 678,884 -7,365 | -1% | -$827K |
|
|
HZNP
3
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $63.5M | 3.29% | +1,142,478 | New | +$63.5M |
|
4
AbbVie
ABBV
$372B
| $63.3M | 3.28% | 644,588 -79,586 | -11% | -$7.81M |
|
5
BioMarin Pharmaceuticals
BMRN
$11.2B
| $59.6M | 3.09% | 483,079 +83,474 | +21% | +$10.3M |
|
6
Gilead Sciences
GILD
$140B
| $51.8M | 2.69% | 673,412 +120,073 | +22% | +$9.24M |
|
|
7
Labcorp
LH
$23.1B
| $51.5M | 2.67% | +310,330 | New | +$51.5M |
|
8
McKesson
MCK
$85.4B
| $50.5M | 2.62% | 329,175 -14,775 | -4% | -$2.27M |
|
9
Cardinal Health
CAH
$35.5B
| $45.2M | 2.34% | 865,933 -12,598 | -1% | -$657K |
|
10
Arcus Biosciences
RCUS
$1.13B
| $42.9M | 2.23% | 1,735,581 +926,070 | +114% | +$22.9M |
|
11
ICU Medical
ICUI
$3.15B
| $41.6M | 2.16% | 225,551 +23,212 | +11% | +$4.28M |
|
12
IQVIA
IQV
$32.4B
| $40.8M | 2.12% | 287,538 +130,337 | +83% | +$18.5M |
|
|
KRTX
13
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $39.3M | 2.04% | 352,545 -146,965 | -29% | -$16.4M |
|
|
14
Hologic
HOLX
$14.9B
| $35M | 1.81% | +613,776 | New | +$35M |
|
|
15
AstraZeneca
AZN
$248B
| $33.6M | 1.74% | +635,600 | New | +$33.6M |
|
|
AERI
16
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $33.6M | 1.74% | 2,274,220 -254,056 | -10% | -$3.75M |
|
17
Humana
HUM
$36.5B
| $33.4M | 1.73% | 86,020 -17,010 | -17% | -$6.6M |
|
18
Heron Therapeutics
HRTX
$207M
| $32.8M | 1.7% | 2,231,402 -250,515 | -10% | -$3.69M |
|
19
HCA Healthcare
HCA
$94.5B
| $32M | 1.66% | 329,357 +143,508 | +77% | +$13.9M |
|
|
CNST
20
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $31.6M | 1.64% | 1,051,390 +735,496 | +233% | +$22.1M |
|
21
Danaher
DHR
$147B
| $30.5M | 1.58% | +172,321 | New | +$30.5M |
|
22
iRhythm Technologies
IRTC
$5.46B
| $28.8M | 1.49% | 248,558 +15,149 | +6% | +$1.76M |
|
|
PPD
23
DELISTED
PPD, Inc. Common Stock
PPD
| $28.8M | 1.49% | 1,073,491 +595,748 | +125% | +$16M |
|
24
Edwards Lifesciences
EW
$47.8B
| $27.2M | 1.41% | 393,435 +275,043 | +232% | +$19M |
|
|
25
Elevance Health
ELV
$71.8B
| $26.3M | 1.36% | 100,000 -123,925 | -55% | -$32.6M |
|